Allarity Total Assets from 2010 to 2025

ALLR Stock

USD 1.03 0.02 1.90%

Allarity Therapeutics Total Assets yearly trend continues to be relatively stable with very little volatility. Total Assets are likely to drop to about 10.1 M. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2010-12-31

Previous Quarter

10.7 M

Current Value

10.1 M

Quarterly Volatility

10.6 M

Credit Downgrade

Yuan Drop

Covid

Check Allarity Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Allarity Therapeutics' main balance sheet or income statement drivers, such as Interest Expense of 543.9 K, Interest Income of 36.2 K or Depreciation And Amortization of 31.6 K, as well as many indicators such as Price To Sales Ratio of 312, Dividend Yield of 0.0 or Days Sales Outstanding of 4.8 K. Allarity financial statements analysis is a perfect complement when working with Allarity Therapeutics Valuation or Volatility modules.

Check out the analysis of Allarity Therapeutics Correlation against competitors.

To learn how to invest in Allarity Stock, please use our How to Invest in Allarity Therapeutics guide.

Latest Allarity Therapeutics' Total Assets Growth Pattern

Below is the plot of the Total Assets of Allarity Therapeutics over the last few years. Total assets refers to the total amount of Allarity Therapeutics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Allarity Therapeutics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Allarity Therapeutics' Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Allarity Therapeutics' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 11.86 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

Allarity Total Assets Regression Statistics

	Arithmetic Mean	27,895,613
	Geometric Mean	25,441,762
	Coefficient Of Variation	38.02
	Mean Deviation	8,044,830
	Median	31,607,000
	Standard Deviation	10,607,054
	Sample Variance	112.5T
	Range	39.5M
	R-Value	(0.55)
	Mean Square Error	84.4T
	R-Squared	0.30
	Significance	0.03
	Slope	(1,220,118)
	Total Sum of Squares	1687.6T

Allarity Total Assets History

	2025	10.1 M
	2024	10.7 M
	2023	11.9 M
	2022	14.5 M
	2021	49.6 M
	2020	33.4 M

Other Fundumenentals of Allarity Therapeutics

Intangibles To Total Assets

Allarity Therapeutics Total Assets component correlations

	Net Tangible Assets	Retained Earnings	Accounts Payable	Net Receivables	Total Current Assets	Common Stock	Property Plant Equipment	Total Assets	Total Stockholder Equity	Net Debt	Total Liab	Net Invested Capital	Long Term Investments	Short Long Term Debt	Capital Stock	Net Working Capital	Short Term Debt	Intangible Assets	Long Term Debt	Current Deferred Revenue	Short Term Investments	Capital Surpluse	Deferred Long Term Liab
Net Tangible Assets		0.11	-0.63	-0.58	-0.21	-0.43	-0.34	-0.03	-0.05	0.0	0.02	-0.05	-0.05	0.0	0.0	-0.02	0.01	-0.04	0.03	-0.03	-0.03	-0.01	-0.01
Retained Earnings	0.11		-0.63	0.33	0.2	0.72	0.46	0.72	0.91	-0.01	-0.51	0.91	-0.36	-0.66	-0.81	0.84	-0.58	0.89	-0.89	0.92	0.92	0.57	0.57
Accounts Payable	-0.63	-0.63		0.36	-0.17	-0.08	-0.25	-0.61	-0.58	0.37	-0.03	-0.58	0.06	0.09	0.39	-0.57	0.38	-0.6	0.53	-0.56	-0.56	-0.28	-0.28
Net Receivables	-0.58	0.33	0.36		0.5	0.82	-0.15	0.35	0.43	0.05	-0.32	0.42	-0.54	-0.57	-0.64	0.5	-0.46	0.47	-0.54	0.52	0.52	0.33	0.33
Total Current Assets	-0.21	0.2	-0.17	0.5		0.48	-0.29	0.76	0.47	-0.81	0.51	0.46	-0.39	0.07	-0.41	0.67	-0.61	0.49	-0.38	0.54	0.54	0.4	0.4
Common Stock	-0.43	0.72	-0.08	0.82	0.48		0.23	0.69	0.84	-0.07	-0.42	0.84	-0.29	-0.59	-0.74	0.76	-0.57	0.83	-0.82	0.85	0.85	0.52	0.52
Property Plant Equipment	-0.34	0.46	-0.25	-0.15	-0.29	0.23		0.21	0.39	0.1	-0.3	0.39	0.29	-0.12	-0.08	0.17	-0.01	0.32	-0.29	0.28	0.28	0.17	0.17
Total Assets	-0.03	0.72	-0.61	0.35	0.76	0.69	0.21		0.89	-0.67	0.14	0.88	-0.27	-0.21	-0.65	0.91	-0.74	0.88	-0.75	0.9	0.9	0.61	0.61
Total Stockholder Equity	-0.05	0.91	-0.58	0.43	0.47	0.84	0.39	0.89		-0.27	-0.31	1.0	-0.21	-0.46	-0.73	0.9	-0.62	0.95	-0.9	0.97	0.97	0.63	0.63
Net Debt	0.0	-0.01	0.37	0.05	-0.81	-0.07	0.1	-0.67	-0.27		-0.83	-0.26	0.05	-0.41	0.07	-0.41	0.48	-0.3	0.08	-0.31	-0.31	-0.19	-0.19
Total Liab	0.02	-0.51	-0.03	-0.32	0.51	-0.42	-0.3	0.14	-0.31	-0.83		-0.32	0.13	0.68	0.38	-0.14	-0.12	-0.25	0.47	-0.26	-0.26	-0.26	-0.26
Net Invested Capital	-0.05	0.91	-0.58	0.42	0.46	0.84	0.39	0.88	1.0	-0.26	-0.32		-0.19	-0.44	-0.72	0.9	-0.58	0.94	-0.9	0.96	0.96	0.65	0.65
Long Term Investments	-0.05	-0.36	0.06	-0.54	-0.39	-0.29	0.29	-0.27	-0.21	0.05	0.13	-0.19		0.6	0.74	-0.51	0.57	-0.29	0.42	-0.41	-0.41	-0.37	-0.37
Short Long Term Debt	0.0	-0.66	0.09	-0.57	0.07	-0.59	-0.12	-0.21	-0.46	-0.41	0.68	-0.44	0.6		0.83	-0.41	0.59	-0.55	0.65	-0.58	-0.58	-0.27	-0.27
Capital Stock	0.0	-0.81	0.39	-0.64	-0.41	-0.74	-0.08	-0.65	-0.73	0.07	0.38	-0.72	0.74	0.83		-0.81	0.81	-0.83	0.88	-0.86	-0.86	-0.48	-0.48
Net Working Capital	-0.02	0.84	-0.57	0.5	0.67	0.76	0.17	0.91	0.9	-0.41	-0.14	0.9	-0.51	-0.41	-0.81		-0.68	0.89	-0.86	0.94	0.94	0.64	0.64
Short Term Debt	0.01	-0.58	0.38	-0.46	-0.61	-0.57	-0.01	-0.74	-0.62	0.48	-0.12	-0.58	0.57	0.59	0.81	-0.68		-0.76	0.64	-0.78	-0.78	-0.3	-0.3
Intangible Assets	-0.04	0.89	-0.6	0.47	0.49	0.83	0.32	0.88	0.95	-0.3	-0.25	0.94	-0.29	-0.55	-0.83	0.89	-0.76		-0.93	0.97	0.97	0.46	0.46
Long Term Debt	0.03	-0.89	0.53	-0.54	-0.38	-0.82	-0.29	-0.75	-0.9	0.08	0.47	-0.9	0.42	0.65	0.88	-0.86	0.64	-0.93		-0.92	-0.92	-0.61	-0.61
Current Deferred Revenue	-0.03	0.92	-0.56	0.52	0.54	0.85	0.28	0.9	0.97	-0.31	-0.26	0.96	-0.41	-0.58	-0.86	0.94	-0.78	0.97	-0.92		1.0	0.62	0.62
Short Term Investments	-0.03	0.92	-0.56	0.52	0.54	0.85	0.28	0.9	0.97	-0.31	-0.26	0.96	-0.41	-0.58	-0.86	0.94	-0.78	0.97	-0.92	1.0		0.62	0.62
Capital Surpluse	-0.01	0.57	-0.28	0.33	0.4	0.52	0.17	0.61	0.63	-0.19	-0.26	0.65	-0.37	-0.27	-0.48	0.64	-0.3	0.46	-0.61	0.62	0.62		1.0
Deferred Long Term Liab	-0.01	0.57	-0.28	0.33	0.4	0.52	0.17	0.61	0.63	-0.19	-0.26	0.65	-0.37	-0.27	-0.48	0.64	-0.3	0.46	-0.61	0.62	0.62	1.0

Click cells to compare fundamentals

About Allarity Therapeutics Financial Statements

Allarity Therapeutics shareholders use historical fundamental indicators, such as Total Assets, to determine how well the company is positioned to perform in the future. Although Allarity Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in Allarity Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Allarity Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Total Assets	10.7 M	10.1 M
Intangibles To Total Assets	0.75	0.58

Pair Trading with Allarity Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Allarity Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Allarity Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving together with Allarity Stock

0.7	AZN	AstraZeneca PLC ADR	Pair Corr
0.85	GSK	GlaxoSmithKline PLC ADR	Pair Corr
0.61	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.92	NVS	Novartis AG ADR	Pair Corr
0.72	PFE	Pfizer Inc Earnings Call This Week	Pair Corr

Moving against Allarity Stock

0.74	MBFJF	Mitsubishi UFJ Financial	Pair Corr
0.58	GILD	Gilead Sciences	Pair Corr
0.47	LH	Laboratory	Pair Corr

The ability to find closely correlated positions to Allarity Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Allarity Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Allarity Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Allarity Therapeutics to buy it.

The correlation of Allarity Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Allarity Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Allarity Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Allarity Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Additional Tools for Allarity Stock Analysis

When running Allarity Therapeutics' price analysis, check to measure Allarity Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Allarity Therapeutics is operating at the current time. Most of Allarity Therapeutics' value examination focuses on studying past and present price action to predict the probability of Allarity Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Allarity Therapeutics' price. Additionally, you may evaluate how the addition of Allarity Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC